Zobrazeno 1 - 10
of 396
pro vyhledávání: '"MVI"'
Publikováno v:
Asian Journal of Surgery, Vol 47, Iss 5, Pp 2138-2143 (2024)
Summary: Hepatectomy is widely considered a potential treatment for hepatocellular carcinoma (HCC). Unfortunately, one-third of HCC patients have tumor recurrence within 2 years after surgery (early recurrence), accounting for more than 60% of all re
Externí odkaz:
https://doaj.org/article/5c0d9be3f5424c39bb30da0a1f199cd3
Autor:
Guangchao Hu, Jianyi Qu, Jie Gao, Yuqian Chen, Fang Wang, Haicheng Zhang, Han Zhang, Xuefeng Wang, Heng Ma, Haizhu Xie, Cong Xu, Naixuan Li, Qianqian Zhang
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
PurposeThis study aimed to develop and validate a radiogenomics nomogram for predicting microvascular invasion (MVI) in hepatocellular carcinoma (HCC) on the basis of MRI and microRNAs (miRNAs).Materials and methodsThis cohort study included 168 pati
Externí odkaz:
https://doaj.org/article/4ab072f21f2d4b0caad544a3a77cb9b9
Autor:
Yaru Wang, Bo Meng, Xijun Wang, Anke Wu, Xiaoyu Li, Xiaohong Qian, Jianxiong Wu, Wantao Ying, Ting Xiao, Weiqi Rong
Publikováno v:
BMC Medicine, Vol 21, Iss 1, Pp 1-13 (2023)
Abstract Background Microvascular invasion (MVI) is the main factor affecting the prognosis of patients with hepatocellular carcinoma (HCC). The aim of this study was to identify accurate diagnostic biomarkers from urinary protein signatures for preo
Externí odkaz:
https://doaj.org/article/7aebcddbc7c0492285c2925dd6878c2f
Autor:
Mengqi Huang, Fan Zhang, Zhen Li, Yan Luo, Jiali Li, Zixiong Wang, Liya Ma, Gen Chen, Xuemei Hu
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Externí odkaz:
https://doaj.org/article/1b7554b4f97245319d93bbd4d2383431
Autor:
Mengqi Huang, Fan Zhang, Zhen Li, Yan Luo, Jiali Li, Zixiong Wang, Liya Ma, Gen Chen, Xuemei Hu
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
PurposeTo assess the utility of fat fraction quantification using quantitative multi-echo Dixon for evaluating tumor proliferation and microvascular invasion (MVI) in hepatocellular carcinoma (HCC).MethodsA total of 66 patients with resection and his
Externí odkaz:
https://doaj.org/article/56cb5f8a87474044be72de30c8db0103
Autor:
Zong‐Han Liu, Zong‐Tao Chai, Jin‐Kai Feng, Yu‐Chao Hou, Xiu‐Ping Zhang, Zhen‐Hua Chen, Yan‐Jun Xiang, Wei‐Xing Guo, Jie Shi, Shu‐Qun Cheng
Publikováno v:
Cancer Medicine, Vol 12, Iss 9, Pp 10294-10302 (2023)
Abstract Background Early and late recurrence of hepatocellular carcinoma (HCC) have different clinical outcomes, especially for those accompanied by microvascular invasion (MVI), but the definition of early recurrence remains controversial. Therefor
Externí odkaz:
https://doaj.org/article/ecc77391e83c454b8fa8ab123bd7951a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundEarly tumor recurrence is one of the most significant poor prognostic factors for patients with HCC after R0 resection. The aim of this study is to identify risk factors of early recurrence, in addition, to develop a nomogram model predicti
Externí odkaz:
https://doaj.org/article/b6aa7af7a8c04258b8361af30d43c175
Publikováno v:
Translational Oncology, Vol 27, Iss , Pp 101597- (2023)
Purpose: To establish and validate a nomogram model incorporating both liver imaging reporting and data system (LI-RADS) features and contrast enhanced magnetic resonance imaging (CEMRI)-based radiomics for predicting microvascular invasion (MVI) in
Externí odkaz:
https://doaj.org/article/8571d8a9a3b3432db5def9540c9fadbc